Latest News and Press Releases
Want to stay updated on the latest news?
-
The statement is based on a report which BoConcept Holding A/S has received from one of the Executives on 5 December 2013. Name: Kirk...
-
Stockholm - Tele2 AB, ("Tele2"), (OMX Nordiska Börsen: TEL2 A and TEL2 B), meddelade idag att man inte erhållit några frekvenser i mulitbandsauktionen som hölls i Norge den 2 december. Tele2 Norge...
-
Stockholm – Tele2 AB (Tele2), (NASDAQ OMX Stockholm Exchange: TEL2 A and TEL2 B), today announced that it did not obtain any resources in the multiband frequency auction held in Norway on December...
-
Riga, 2013-12-06 07:30 CET (GLOBE NEWSWIRE) -- The meeting between management of companies AS “Telekom Baltija” working under the brand “Triatel” and AS “Baltic Telekom” took place in Riga on...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BOUSSARD...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BOUSSARD...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Ascencio a clôturé un nouvel exercice très...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox finalise l'acquisition d'Eupharmed...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Nicox completes the acquisition of Eupharmed ...
-
Study of LBH589 plus bortezomib and dexamethasone met primary endpoint of extending PFS compared to bortezomib plus dexamethasone and placebo LBH589 has potential to be the first in its class of...